Skip to main content
Erschienen in: Journal of Neurology 12/2009

01.12.2009 | Original Communication

Charcot–Marie–Tooth disease type 2J with MPZ Thr124Met mutation: clinico-electrophysiological and MRI study of a family

verfasst von: Elena Gallardo, Antonio García, César Ramón, Elías Maraví, Jon Infante, Itziar Gastón, Ángel Alonso, Onofre Combarros, Peter De Jonghe, José Berciano

Erschienen in: Journal of Neurology | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

The purpose of the present study was to describe clinico-electrophysiological features and lower limb muscle MRI findings in a CMT2J pedigree due to MPZ Thr124Met mutation. We examined the proband, aged 56 years, and her affected daughter and son, aged 30 and 29 years. Disease severity in terms of ability to walk and run was established using a nine-point functional disability scale (FDS). We administered the CMT neuropathy score (CMTNS) based on patient’s symptoms, neurologic examination and neurophysiologic testing. All three patients had non-symptomatic Adie’s pupil. The proband and her son presented with late-onset lower limb sensorimotor neuropathy and pes cavus; the proband’s daughter had no signs of polyneuropathy. FDS score was 4 in the proband, 2 in her son, and 0 (normal) in her daughter. In both symptomatic patients, electrophysiological study showed a pattern of length-dependent axonal neuropathy mainly involving lower limb nerves; this was normal in the other patient. CMTNS was 18 in the proband, 12 in her son, and 0 (normal) in her daughter. MRI of foot and leg musculature was normal in the proband’s daughter, whereas the other two patients showed massive fatty atrophy of intrinsic foot musculature, extensive and diffuse fatty atrophy of leg muscles in the proband, and mild distally accentuated fatty infiltration of calf muscles in her son. Muscle edema, detected only in the proband’s son, was present in 7 out of 22 (33%) of visualized leg muscles, whereas contrast enhancement occurred in 6 of them. The reported mutation may manifest with either isolated Adie’s pupil or pupil abnormalities with late-onset sensorimotor length-dependent axonal polyneuropathy, though the presence of pes cavus might indicate an earlier onset. MRI examination helps to delineate an accurate extent of muscle involvement in the disease.
Literatur
1.
Zurück zum Zitat Alexander IJ, Johnson KA (1989) Assessment and management of pes cavus in Charcot–Marie–Tooth disease. Clin Orthop Relat Res 246:273–281PubMed Alexander IJ, Johnson KA (1989) Assessment and management of pes cavus in Charcot–Marie–Tooth disease. Clin Orthop Relat Res 246:273–281PubMed
2.
Zurück zum Zitat Baloh RH, Jen JC, Kim G, Baloh RW (2004) Chronic cough due to Thr124Met mutation in the peripheral myelin protein zero (MPZ gene). Neurology 62:1905–1906PubMed Baloh RH, Jen JC, Kim G, Baloh RW (2004) Chronic cough due to Thr124Met mutation in the peripheral myelin protein zero (MPZ gene). Neurology 62:1905–1906PubMed
3.
Zurück zum Zitat Berciano J, Combarros O, Calleja J, Polo JM, Leno C (1989) The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I. Muscle Nerve 12:302–306CrossRefPubMed Berciano J, Combarros O, Calleja J, Polo JM, Leno C (1989) The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I. Muscle Nerve 12:302–306CrossRefPubMed
4.
Zurück zum Zitat Berciano J, Gallardo E, García A, Infante J, Mateo I, Combarros O (2006) Charcot–Marie–Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study. J Neurol Neurosurg Psychiatry 77:1169–1176CrossRefPubMed Berciano J, Gallardo E, García A, Infante J, Mateo I, Combarros O (2006) Charcot–Marie–Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study. J Neurol Neurosurg Psychiatry 77:1169–1176CrossRefPubMed
5.
Zurück zum Zitat Berciano J, Gallardo E, García A, Ramón C, Mateo I, Infante J, Rodríguez-Rodríguez E, Combarros O (2008) CMT1A duplication: refining the minimal adult phenotype. J Peripher Nerv Syst 13:310–312CrossRefPubMed Berciano J, Gallardo E, García A, Ramón C, Mateo I, Infante J, Rodríguez-Rodríguez E, Combarros O (2008) CMT1A duplication: refining the minimal adult phenotype. J Peripher Nerv Syst 13:310–312CrossRefPubMed
6.
Zurück zum Zitat Bienfait HM, Verhamme C, van Schaik IN, Koelman JH, de Visser BW, de Haan RJ, Baas F, van Engelen BG, de Visser M (2006) Comparison of CMT1A and CMT2: similarities and differences. J Neurol 253:1572–1580CrossRefPubMed Bienfait HM, Verhamme C, van Schaik IN, Koelman JH, de Visser BW, de Haan RJ, Baas F, van Engelen BG, de Visser M (2006) Comparison of CMT1A and CMT2: similarities and differences. J Neurol 253:1572–1580CrossRefPubMed
7.
Zurück zum Zitat Bird TD, Kraft GH, Lipe HP, Kenney KL, Sumi SM (1997) Clinical and pathological phenotype of the original family with Charcot–Marie–Tooth type 1B: a 20-year study. Ann Neurol 41:463–469CrossRefPubMed Bird TD, Kraft GH, Lipe HP, Kenney KL, Sumi SM (1997) Clinical and pathological phenotype of the original family with Charcot–Marie–Tooth type 1B: a 20-year study. Ann Neurol 41:463–469CrossRefPubMed
8.
Zurück zum Zitat Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonabe T, Le Forestier N, Agid Y, Brice A, Bouche P (1997) Charcot–Marie–Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813–823CrossRefPubMed Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonabe T, Le Forestier N, Agid Y, Brice A, Bouche P (1997) Charcot–Marie–Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813–823CrossRefPubMed
9.
Zurück zum Zitat Briani C, Adami F, Cavallaro T, Taioli F, Ferrari S, Fabrizi G (2008) Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy. Muscle Nerve 38:921–923CrossRefPubMed Briani C, Adami F, Cavallaro T, Taioli F, Ferrari S, Fabrizi G (2008) Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy. Muscle Nerve 38:921–923CrossRefPubMed
10.
Zurück zum Zitat Burns J, Ryan MM, Ouvrier RA (2009) Evolution of foot and ankle manifestations in children with CMT1A. Muscle Nerve 39:158–166CrossRefPubMed Burns J, Ryan MM, Ouvrier RA (2009) Evolution of foot and ankle manifestations in children with CMT1A. Muscle Nerve 39:158–166CrossRefPubMed
11.
Zurück zum Zitat Chapon F, Latour P, Diraison P, Schaeffer S, Vandenberghe A (1999) Axonal phenotype of Charcot–Marie–Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry 66:779–782CrossRefPubMed Chapon F, Latour P, Diraison P, Schaeffer S, Vandenberghe A (1999) Axonal phenotype of Charcot–Marie–Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry 66:779–782CrossRefPubMed
12.
Zurück zum Zitat Chiappa KH (1983) Evoked potentials in clinical medicine. Raven Press, New York Chiappa KH (1983) Evoked potentials in clinical medicine. Raven Press, New York
13.
Zurück zum Zitat Chung KW, Kim SB, Park KD, Choi KG, Lee JH, Eun HW, Suh JS, Hwang JH, Kim WK, Seo BC, Kim SH, Son IH, Kim SM, Sunwoo IN, Choi BO (2006) Early onset severe and late-onset mild Charcot–Marie–Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129:2103–2118CrossRefPubMed Chung KW, Kim SB, Park KD, Choi KG, Lee JH, Eun HW, Suh JS, Hwang JH, Kim WK, Seo BC, Kim SH, Son IH, Kim SM, Sunwoo IN, Choi BO (2006) Early onset severe and late-onset mild Charcot–Marie–Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129:2103–2118CrossRefPubMed
14.
Zurück zum Zitat Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, Choi KG, Kim S, Kim SB, Shim DS, Kim SM, Sunwoo IN, Choi BO (2008) Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A. Neuromuscul Disord 18:610–618CrossRefPubMed Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, Choi KG, Kim S, Kim SB, Shim DS, Kim SM, Sunwoo IN, Choi BO (2008) Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A. Neuromuscul Disord 18:610–618CrossRefPubMed
15.
Zurück zum Zitat De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Löfgren A, Vercruyssen A, Verellen C, Van Maldergem L, Martin JJ, Van Broeckhoven C (1999) The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot–Marie–Tooth phenotype. Brain 122:281–290CrossRefPubMed De Jonghe P, Timmerman V, Ceuterick C, Nelis E, De Vriendt E, Löfgren A, Vercruyssen A, Verellen C, Van Maldergem L, Martin JJ, Van Broeckhoven C (1999) The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot–Marie–Tooth phenotype. Brain 122:281–290CrossRefPubMed
16.
Zurück zum Zitat Fabrizi GM, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, Bertolasi L, Rizzuto N (2007) Two novel mutations in dynamin-2 cause axonal Charcot–Marie–Tooth disease. Neurology 69:291–295CrossRefPubMed Fabrizi GM, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, Bertolasi L, Rizzuto N (2007) Two novel mutations in dynamin-2 cause axonal Charcot–Marie–Tooth disease. Neurology 69:291–295CrossRefPubMed
17.
Zurück zum Zitat Farber JM, Buckwalter KA (2002) MR imaging in nonneoplastic muscle disorders of the lower extremity. Radiol Clin North Am 40:1013–1031CrossRefPubMed Farber JM, Buckwalter KA (2002) MR imaging in nonneoplastic muscle disorders of the lower extremity. Radiol Clin North Am 40:1013–1031CrossRefPubMed
18.
Zurück zum Zitat Fleckenstein JL, Watumull D, Conner KE, Ezaki M, Greenlee RG Jr, Bryan WW, Chason DP, Parkey RW, Peshock RM, Purdy PD (1993) Denervated human skeletal muscle: MR imaging evaluation. Radiology 187:213–218PubMed Fleckenstein JL, Watumull D, Conner KE, Ezaki M, Greenlee RG Jr, Bryan WW, Chason DP, Parkey RW, Peshock RM, Purdy PD (1993) Denervated human skeletal muscle: MR imaging evaluation. Radiology 187:213–218PubMed
19.
Zurück zum Zitat Gabriel CM, Gregson NA, Wood NW, Hughes RAC (2002) Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN type I). J Neurol Neurosurg Psychiatry 72:230–235CrossRefPubMed Gabriel CM, Gregson NA, Wood NW, Hughes RAC (2002) Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN type I). J Neurol Neurosurg Psychiatry 72:230–235CrossRefPubMed
20.
Zurück zum Zitat Gallardo E, García A, Combarros O, Berciano J (2006) Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437CrossRefPubMed Gallardo E, García A, Combarros O, Berciano J (2006) Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437CrossRefPubMed
21.
Zurück zum Zitat Gallardo E, Claeys KG, Nelis E, García A, Canga A, Combarros O, Timmerman V, De Jonghe P, Berciano J (2008) Magnetic resonance imaging findings of leg musculature in Charcot–Marie–Tooth disease type 2 due to dynamin 2 mutation. J Neurol 255:986–992CrossRefPubMed Gallardo E, Claeys KG, Nelis E, García A, Canga A, Combarros O, Timmerman V, De Jonghe P, Berciano J (2008) Magnetic resonance imaging findings of leg musculature in Charcot–Marie–Tooth disease type 2 due to dynamin 2 mutation. J Neurol 255:986–992CrossRefPubMed
22.
Zurück zum Zitat García A, Combarros O, Calleja J, Berciano J (1998) Charcot–Marie–Tooth disease type 1A with 17p duplication in early infancy and childhood. A longitudinal clinical and electrophysiological study. Neurology 50:1061–1067PubMed García A, Combarros O, Calleja J, Berciano J (1998) Charcot–Marie–Tooth disease type 1A with 17p duplication in early infancy and childhood. A longitudinal clinical and electrophysiological study. Neurology 50:1061–1067PubMed
23.
Zurück zum Zitat Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, Winer JB, Orrell RW, King RH (2004) Coexistent hereditary and inflammatory neuropathy. Brain 127:193–202CrossRefPubMed Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, Winer JB, Orrell RW, King RH (2004) Coexistent hereditary and inflammatory neuropathy. Brain 127:193–202CrossRefPubMed
24.
Zurück zum Zitat Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC (1994) Fatty muscle degeneration in cuff ruptures. Pre- and post-operative evaluation by CT scan. Clin Orthop Relat Res 304:78–83PubMed Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC (1994) Fatty muscle degeneration in cuff ruptures. Pre- and post-operative evaluation by CT scan. Clin Orthop Relat Res 304:78–83PubMed
25.
Zurück zum Zitat Grant IA, Benstead TJ (2005) Differential diagnosis of polyneuropathy. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier Saunders, Philadelphia, pp 1163–1180 Grant IA, Benstead TJ (2005) Differential diagnosis of polyneuropathy. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier Saunders, Philadelphia, pp 1163–1180
26.
Zurück zum Zitat Guyton GP (2006) Current concepts review: orthopaedic aspects of Charcot–Marie–Tooth disease. Foot Ankle Int 27:1003–1010PubMed Guyton GP (2006) Current concepts review: orthopaedic aspects of Charcot–Marie–Tooth disease. Foot Ankle Int 27:1003–1010PubMed
27.
Zurück zum Zitat Kimura J (1984) Electrodiagnosis in diseases of nerve and muscle: principles and practice. FA Davis Co, Philadelphia, pp 399–427 Kimura J (1984) Electrodiagnosis in diseases of nerve and muscle: principles and practice. FA Davis Co, Philadelphia, pp 399–427
28.
Zurück zum Zitat Kurihara S, Adachi Y, Wada K, Adachi A, Ohama E, Nakashima K (2003) Axonal and demyelinating forms of the MPZ Thr124Met mutation. Acta Neurol Scand 108:157–160CrossRefPubMed Kurihara S, Adachi Y, Wada K, Adachi A, Ohama E, Nakashima K (2003) Axonal and demyelinating forms of the MPZ Thr124Met mutation. Acta Neurol Scand 108:157–160CrossRefPubMed
29.
Zurück zum Zitat Kurihara S, Adachi Y, Imai C, Araki H, Hattori N, Numakura C, Lin Y, Hayasaka K, Sobue G, Nakashima K (2004) Charcot–Marie–Tooth families in Japan with MPZ Thr124Met mutation. J Neurol Neurosurg Psychiatry 75:1492–1494CrossRefPubMed Kurihara S, Adachi Y, Imai C, Araki H, Hattori N, Numakura C, Lin Y, Hayasaka K, Sobue G, Nakashima K (2004) Charcot–Marie–Tooth families in Japan with MPZ Thr124Met mutation. J Neurol Neurosurg Psychiatry 75:1492–1494CrossRefPubMed
30.
Zurück zum Zitat Leal A, Berghoff C, Berghoff M, Del Valle G, Contreras C, Montoya O, Hernández E, Barrantes R, Schlötzer-Schrehardt U, Neundörfer B, Reis A, Rautenstrauss B, Heuss D (2003) Charcot–Marie–Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family. Neurogenetics 4:191–197CrossRefPubMed Leal A, Berghoff C, Berghoff M, Del Valle G, Contreras C, Montoya O, Hernández E, Barrantes R, Schlötzer-Schrehardt U, Neundörfer B, Reis A, Rautenstrauss B, Heuss D (2003) Charcot–Marie–Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family. Neurogenetics 4:191–197CrossRefPubMed
31.
Zurück zum Zitat May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ (2000) Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. RadoGraphics 20:S295–S313 May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ (2000) Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. RadoGraphics 20:S295–S313
32.
Zurück zum Zitat Mercuri E, Jungbluth H, Muntoni F (2005) Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 18:526–537CrossRefPubMed Mercuri E, Jungbluth H, Muntoni F (2005) Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 18:526–537CrossRefPubMed
33.
Zurück zum Zitat Misu K, Yoshihara T, Shikama Y, Awaki E, Yamamoto M, Hattori N, Hirayama M, Takegami T, Nakashima K, Sobue G (2000) An axonal form of Charcot–Marie–Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry 69:806–811CrossRefPubMed Misu K, Yoshihara T, Shikama Y, Awaki E, Yamamoto M, Hattori N, Hirayama M, Takegami T, Nakashima K, Sobue G (2000) An axonal form of Charcot–Marie–Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry 69:806–811CrossRefPubMed
34.
Zurück zum Zitat Nelis E, Warner LE, Vriendt ED, Chance PF, Lupski JR, Van Broeckhoven C (1996) Comparison of single-strand conformation polymorphism and heteroduplex analysis for detection of mutations in Charcot–Marie–Tooth type 1 disease and related peripheral neuropathies. Eur J Hum Genet 4:329–333PubMed Nelis E, Warner LE, Vriendt ED, Chance PF, Lupski JR, Van Broeckhoven C (1996) Comparison of single-strand conformation polymorphism and heteroduplex analysis for detection of mutations in Charcot–Marie–Tooth type 1 disease and related peripheral neuropathies. Eur J Hum Genet 4:329–333PubMed
35.
Zurück zum Zitat Preston DC, Shapiro BE (2005) Electromyography and neuromuscular disorders. Elsevier Butterworth Heinemann, Philadelphia Preston DC, Shapiro BE (2005) Electromyography and neuromuscular disorders. Elsevier Butterworth Heinemann, Philadelphia
36.
Zurück zum Zitat Seeman P, Mazanec R, Huehne K, Suslíková P, Keller O, Rautenstrauss B (2004) Hearing loss as the first feature of late-onset axonal CMT disease due to a novel P0 mutation. Neurology 63:733–735PubMed Seeman P, Mazanec R, Huehne K, Suslíková P, Keller O, Rautenstrauss B (2004) Hearing loss as the first feature of late-onset axonal CMT disease due to a novel P0 mutation. Neurology 63:733–735PubMed
37.
Zurück zum Zitat Senderek J, Hermanns B, Lehmann U, Bergmann C, Marx G, Kabus C, Timmerman V, Stoltenburg-Didinger G, Schröder JM (2000) Charcot–Marie–Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible “hotspot” on Thr124Met. Brain Pathol 10:235–248PubMedCrossRef Senderek J, Hermanns B, Lehmann U, Bergmann C, Marx G, Kabus C, Timmerman V, Stoltenburg-Didinger G, Schröder JM (2000) Charcot–Marie–Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible “hotspot” on Thr124Met. Brain Pathol 10:235–248PubMedCrossRef
38.
Zurück zum Zitat Shy ME, Jáni A, Krajewski K, Grandis M, Lewis RA, Li J, Shy RR, Balsamo J, Lilien J, Garbern JY, Kamholz J (2004) Phenotypic clustering in MPZ mutations. Brain 127:371–384CrossRefPubMed Shy ME, Jáni A, Krajewski K, Grandis M, Lewis RA, Li J, Shy RR, Balsamo J, Lilien J, Garbern JY, Kamholz J (2004) Phenotypic clustering in MPZ mutations. Brain 127:371–384CrossRefPubMed
39.
Zurück zum Zitat Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214PubMed Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214PubMed
40.
Zurück zum Zitat Stillwell G, Kilcoyne RF, Sherman JL (1995) Patterns of muscle atrophy in the lower limbs in patients with Charcot–Marie–Tooth disease as measured by magnetic resonance imaging. J Foot Ankle Surg 34:583–586CrossRef Stillwell G, Kilcoyne RF, Sherman JL (1995) Patterns of muscle atrophy in the lower limbs in patients with Charcot–Marie–Tooth disease as measured by magnetic resonance imaging. J Foot Ankle Surg 34:583–586CrossRef
41.
Zurück zum Zitat Stojkovic T, de Seze J, Dubourg O, Arne-Bes MC, Tardieu S, Hache JC, Vermersch P (2003) Autonomic and respiratory dysfunction in Charcot–Marie–Tooth disease due to Thr124Met mutation in the myelin protein zero gene. Clin Neurophysiol 114:1609–1614CrossRefPubMed Stojkovic T, de Seze J, Dubourg O, Arne-Bes MC, Tardieu S, Hache JC, Vermersch P (2003) Autonomic and respiratory dysfunction in Charcot–Marie–Tooth disease due to Thr124Met mutation in the myelin protein zero gene. Clin Neurophysiol 114:1609–1614CrossRefPubMed
42.
Zurück zum Zitat Thompson PD, Thomas PK (2005) Clinical patterns of peripheral neuropathy. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier Saunders, Philadelphia, pp 1137–1161 Thompson PD, Thomas PK (2005) Clinical patterns of peripheral neuropathy. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier Saunders, Philadelphia, pp 1137–1161
43.
Zurück zum Zitat Triggs WJ, Brown RH Jr, Menkes DL (2006) Case records of the Massachusetts General Hospital. Case 18–2006. A 57-year-old woman with numbness and weakness of the feet and legs. N Engl J Med 354:2584–2592CrossRefPubMed Triggs WJ, Brown RH Jr, Menkes DL (2006) Case records of the Massachusetts General Hospital. Case 18–2006. A 57-year-old woman with numbness and weakness of the feet and legs. N Engl J Med 354:2584–2592CrossRefPubMed
44.
Zurück zum Zitat Tynan MC, Klenerman L, Helliwell TR, Edwards RHT, Hayward M (1992) Investigation of muscle imbalance in the leg in symptomatic forefoot pes cavus: a multidisciplinary study. Foot Ankle 13:490–501 Tynan MC, Klenerman L, Helliwell TR, Edwards RHT, Hayward M (1992) Investigation of muscle imbalance in the leg in symptomatic forefoot pes cavus: a multidisciplinary study. Foot Ankle 13:490–501
45.
Zurück zum Zitat Wang Ip C, Kroner A, Fischer S, Berghoff M, Kobsar I, Mäurer M, Martini R (2006) Role of immune cells in animal models for inherited peripheral neuropathies. Neuromolecular Med 8:175–190CrossRefPubMed Wang Ip C, Kroner A, Fischer S, Berghoff M, Kobsar I, Mäurer M, Martini R (2006) Role of immune cells in animal models for inherited peripheral neuropathies. Neuromolecular Med 8:175–190CrossRefPubMed
46.
Zurück zum Zitat West GA, Haynor DR, Goodkin R, Tsuruda JS, Bronstein AD, Kraft G, Winter T, Kliot M (1994) Magnetic resonance imaging signal changes in denervated muscles after peripheral nerve injury. Neurosurgery 35:1077–1085CrossRefPubMed West GA, Haynor DR, Goodkin R, Tsuruda JS, Bronstein AD, Kraft G, Winter T, Kliot M (1994) Magnetic resonance imaging signal changes in denervated muscles after peripheral nerve injury. Neurosurgery 35:1077–1085CrossRefPubMed
47.
Zurück zum Zitat Wilhelm H (1998) Neuro-ophthalmology of pupillary function – practical guidelines. J Neurol 245:573–583CrossRefPubMed Wilhelm H (1998) Neuro-ophthalmology of pupillary function – practical guidelines. J Neurol 245:573–583CrossRefPubMed
48.
Zurück zum Zitat Wines AP, Chen D, Lynch B, Stephens MM (2005) Foot deformities in children with hereditary motor and sensory neuropathy. J Pediatr Orthop 25:241–244CrossRefPubMed Wines AP, Chen D, Lynch B, Stephens MM (2005) Foot deformities in children with hereditary motor and sensory neuropathy. J Pediatr Orthop 25:241–244CrossRefPubMed
49.
Zurück zum Zitat Züchner S, Vance JM (2006) Molecular genetics of autosomal-dominant axonal Charcot–Marie–Tooth disease. Neuromolecular Med 8:63–74CrossRefPubMed Züchner S, Vance JM (2006) Molecular genetics of autosomal-dominant axonal Charcot–Marie–Tooth disease. Neuromolecular Med 8:63–74CrossRefPubMed
Metadaten
Titel
Charcot–Marie–Tooth disease type 2J with MPZ Thr124Met mutation: clinico-electrophysiological and MRI study of a family
verfasst von
Elena Gallardo
Antonio García
César Ramón
Elías Maraví
Jon Infante
Itziar Gastón
Ángel Alonso
Onofre Combarros
Peter De Jonghe
José Berciano
Publikationsdatum
01.12.2009
Verlag
D. Steinkopff-Verlag
Erschienen in
Journal of Neurology / Ausgabe 12/2009
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5251-y

Weitere Artikel der Ausgabe 12/2009

Journal of Neurology 12/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.